Creative Enzymes Launches Advanced Neuraminidase for Flu Vaccine Development

The Jewish General Hospital and the CIUSSS du Centre-Ouest-de-l’Ile-de-Montréal Partner with MDClone to Deliver Better Data-Driven Care for Patients

US Orthopedic Alliance Selects 2bPrecise to Accelerate Precision Medicine Program

US Orthopedic Alliance (USOA) selected 2bPrecise to provide its precision medicine platform to USOA’s network of more than 100 orthopedic surgeons.

Sensyne Health Signs Strategic Research Agreement with the Colorado Center for Personalized Medicine

Pronalyse's Comprehensive Biosimilar Analysis Solutions Support Your Drug Discovery

ATMPS and Ori Biotech Collaborate on an Integrated Digital Platform for Cell and Gene Therapy Developers

The collaboration will improve visibility and reporting of cell and gene therapy manufacturing through a pre-integrated data solution

News Update: MedAI Integrates AIDD Platform, CADD Platform, and Experimental Validation Platform for Drug Discovery

Earlier this month, MedAI announces that it has integrated its three AI-powered drug discovery platforms so as to increase drug candidate efficacy and safety throughout the preclinical research. Previously, the company has released AIDD Platform, CADD Platform, and Experimental Validation Platform, which consist of proprietary hardware, biological, molecular and digital technologies.

VERICHEM LABORATORIES OFFERS FREE CLIA COMPLIANT, WEB-BASED CALIBRATION VERIFICATION DATA REDUCTION SERVICES

VERICHEM now furnishes all customers free access to the company’s online, web-based, data reduction services, designed specifically for use with the company's broad line of clinical reference materials,

Alfa Chemistry Released Four Types of Featured Products for the Research Community

In an effort to combine what the customers truly need and what the company provides, Alfa Chemistry recently sorted and released four types of featured products for scientists and researchers who are engaged with the tumor, coronavirus, and flu treatment research as well as the production of personal daily care products.

BC Platforms Partners with TripleBlind to Power Federated Artificial Intelligence (AI) Data Privacy Approaches

DFE Pharma Launches Ultimate Excipient Solution for Biopharma

Cotiviti Appoints RaeAnn L. Grossman as Executive Vice President of Risk Adjustment and Quality to Drive Continued Success and Growth of Company’s Leading Solutions Lines

Seasoned Healthcare Veteran Brings Decades of Experience to Support Company Mission of Lowering Healthcare Costs and Improving Quality for Health Payers, Broader Industry

Microarray Data Analysis Methods Are Now Available at Bioinformatics-Analysis Division of CD Genomics

MicrobioSeq Division Releases Microbial Single-Cell Genome Sequencing to Reveal Heterogeneity of Microbial Populations

Alfa Chemistry Launches a New Sub-Website for the Supply of Graphene and Related CRO Service

Currently graphene has been widely used in modern technology. In order to make graphene products and related CRO services more accessible to scientists and researchers worldwide, Alfa Chemistry announces to have established a new sub-website earlier this month in 2021.

GutFlora Omics Platform Releases Total RNA Sequencing Service

CD BioSciences Provides Case Report Form Design Service for Clinical Trials

CD BioSciences, a supplier of one-stop clinical trial services based in the United States, has released its case report form design service for clinical trials.

Creative Biostructure Updated Its NMR Spectroscopy Services for Science and Pharmaceutical Industry

Bally Ribbon Mills Innovates with New Series of Advanced Textile Products for Electronic Transmission Data, Manufacturing Automation, and Industrial Design

Offering advanced woven webbing used in parachutes, safety harnesses, and protective equipment

Watson-Marlow Fluid Technology Group launches new opinion piece and webinar discussing the manufacturing challenges of personalised medicines

Global leader in fluid management technology, Watson-Marlow Fluid Technology Group (WMFTG), today launches a new article discussing the biopharmaceutical manufacturing challenges of personalised medicines. The opinion piece features insights from bioprocessing experts at WMFTG, Franz Ziel GmbH, Oxford Biomedica and Gemini Bio.